Prospects for new stimulus bill, tensions with China and the pace of new coronavirus infections are weighing on the stock market.
With consumers reluctant to venture out to a lab or doctor’s office, insurers are crunching the data in existing digital records.26
For years, the 10-year U.S. Treasury note has been every investor’s touchstone. Now some people are saying they can’t trust its signals the way they once did.87
Global steel output has fallen during the pandemic, but China’s steps to boost its economy have buoyed local production and with it demand for iron ore.
Some longtime biotech investors are wary of the run-up and warn there are risks to chasing companies at early stages of development.
U.S. stocks have been the better bet for a decade. With those valuations now so high, the question is whether it makes sense to shift some exposure overseas.2
The collective market value of the top 10 companies in the S&P 500 has swelled to about $8 trillion as of Friday, as investors have piled into big technology stocks including.
